Skip to content

Clinical Observation on Acute Pancreatitis Treated by Traditional Chinese Medicine and Western Medicine

Clinical Observation on Acute Pancreatitis Treated by Traditional Chinese Medicine and Western Medicine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2023000023
Enrollment
Unknown
Registered
2023-08-01
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Experiment group 2:XuanBiXieHuang Decoction
Experiment group 1:DaChaiXian Decoction
Control group:Inhibition of pancreatic enzyme secretion, acid suppression, analgesia, nutritional support, etc. (refer to the guidelines)

Sponsors

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria for acute pancreatitis and whose bowel function score is less than or equal to 1 point; 2. Those who are between 18 and 75 years old, regardless of gender; 3. The onset time = 72 hours; 4. .No severe organ dysfunction or local complications; 5. Voluntarily participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who are diagnosed with severe acute pancreatitis (SAP) and have surgical indications; 2. Those who have other serious pancreatic diseases; 3. Those who are combined with severe heart, brain and kidney diseases or cannot tolerate this researcher; 4. Pregnant women and allergies Physical constitution; 5. Those with poor treatment compliance; 6. Those who are currently undergoing chemotherapy, radiotherapy or using immunosuppressive drugs.

Design outcomes

Primary

MeasureTime frame
CT examination of upper abdomen;abdominal pain symptoms;White blood cell;Serum amylase;body temperature;interleukin-6;C reactive protein;TCM Syndrome Points;Defecation;Serum lipase;Nausea and vomiting symptoms;tongue, pulse;Interleukin-10;TNF-a;Bloating Symptoms;Procalcitonin;Burea nitrogen;

Secondary

MeasureTime frame
Balthazar-CT score;Modified Marshall score;APACHE-II score;

Countries

China

Contacts

Public ContactLiu Lijian

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine

liulijian1_0@163.com18007800767

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026